Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 2 Study of Linsitinib (OSI-906) in Pediatric and Adult Wild Type Gastrointestinal Stromal Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01560260
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:09.098751+00:00
Published At
2017-01-19T00:00:00+00:00
Record Updated At
2018-09-21
Results Posted At
2017-01-19
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Carney Complex", "Chondrosarcoma", "Gastrointestinal Stromal Tumor", "Paraganglioma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-09-21"
protocolSection.identificationModule.nctId
"NCT01560260"
protocolSection.identificationModule.officialTitle
"A Phase 2 Study of Linsitinib (OSI-906) in Pediatric and Adult Wild Type Gastrointestinal Stromal Tumors"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2017-01-19"

Study condition terms

  • Carney Complex (protocolSection.conditionsModule.conditions)
  • Chondrosarcoma (protocolSection.conditionsModule.conditions)
  • Gastrointestinal Stromal Tumor (protocolSection.conditionsModule.conditions)
  • Paraganglioma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.